Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition

Published:2017-03 Issue: Volume:104 Page:1-9
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Roh Jong-Lyel,Kim Eun Hye,Jang Hyejin,Shin Daiha

Funder

National Research Foundation of Korea

Ministry of Science, ICT, and Future Planning

Ministry of Health & Welfare, Seoul, Republic of Korea

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference40 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

2. Recent advances in head and neck cancer;Haddad;N. Engl. J. Med.,2008

3. Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: a systematic review and meta-analysis of published studies;Petrelli;Oral. Oncol.,2014

4. Cisplatin in cancer therapy: molecular mechanisms of action;Dasari;Eur. J. Pharmacol.,2014

5. Cisplatin resistance and opportunities for precision medicine;Amable;Pharmacol. Res.,2016

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ursodeoxycholic acid inhibits the uptake of cystine through SLC7A11 and impairs de novo synthesis of glutathione;Journal of Pharmaceutical Analysis;2024-08

2. Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth;Cancer Biology & Therapy;2024-07-25

3. Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers;Nature Reviews Urology;2024-04-16

4. Roles of reactive oxygen species in inflammation and cancer;MedComm;2024-04

5. An Esterase-Responsive SLC7A11 shRNA Delivery System Induced Ferroptosis and Suppressed Hepatocellular Carcinoma Progression;Pharmaceutics;2024-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3